Longchao Liu

1.4k total citations
18 papers, 758 citations indexed

About

Longchao Liu is a scholar working on Immunology, Oncology and Epidemiology. According to data from OpenAlex, Longchao Liu has authored 18 papers receiving a total of 758 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in Longchao Liu's work include Immunotherapy and Immune Responses (10 papers), Hepatitis B Virus Studies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Longchao Liu is often cited by papers focused on Immunotherapy and Immune Responses (10 papers), Hepatitis B Virus Studies (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). Longchao Liu collaborates with scholars based in United States and China. Longchao Liu's co-authors include Yang‐Xin Fu, Hua Peng, Jian Qiao, Lishan Su, Zhichen Sun, Liguo Zhang, Jiahui Chen, Dan Yang, Casey Moore and Zhenhua Ren and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Nature Cell Biology.

In The Last Decade

Longchao Liu

17 papers receiving 750 citations

Peers

Longchao Liu
Xiaotao Jiang China
Nathalie Schmidt United Kingdom
Hiroto Matsui Japan
Nikola Baschuk Australia
Yanan Gao China
Patrick Roelli Switzerland
Francesca Alfei Switzerland
Giovanni Nitti United States
Jolie G. Cullen Australia
Xiaotao Jiang China
Longchao Liu
Citations per year, relative to Longchao Liu Longchao Liu (= 1×) peers Xiaotao Jiang

Countries citing papers authored by Longchao Liu

Since Specialization
Citations

This map shows the geographic impact of Longchao Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Longchao Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Longchao Liu more than expected).

Fields of papers citing papers by Longchao Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Longchao Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Longchao Liu. The network helps show where Longchao Liu may publish in the future.

Co-authorship network of co-authors of Longchao Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Longchao Liu. A scholar is included among the top collaborators of Longchao Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Longchao Liu. Longchao Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Liu, Longchao, et al.. (2024). Assaying antigen-specific T cell trans-endothelial migration <i>in vitro</i> with the Transwell system: application in tumor immunology. Biophysics Reports. 11(3). 156–156. 1 indexed citations
2.
Liu, Longchao, Jiahui Chen, Hongyi Zhang, et al.. (2022). Concurrent delivery of immune checkpoint blockade modulates T cell dynamics to enhance neoantigen vaccine-generated antitumor immunity. Nature Cancer. 3(4). 437–452. 53 indexed citations
3.
Liu, Longchao & Jiahui Chen. (2022). Therapeutic antibodies for precise cancer immunotherapy: current and future perspectives. SHILAP Revista de lepidopterología. 2(6). 555–569. 13 indexed citations
4.
Moore, Casey, Joonbeom Bae, Longchao Liu, et al.. (2022). Exogenous signaling repairs defective T cell signaling inside the tumor microenvironment for better immunity. JCI Insight. 7(17). 4 indexed citations
5.
Bae, Joonbeom, Longchao Liu, Casey Moore, et al.. (2022). IL-2 delivery by engineered mesenchymal stem cells re-invigorates CD8+ T cells to overcome immunotherapy resistance in cancer. Nature Cell Biology. 24(12). 1754–1765. 51 indexed citations
6.
Han, Chuanhui, Victoria Godfrey, Zhida Liu, et al.. (2021). The AIM2 and NLRP3 inflammasomes trigger IL-1–mediated antitumor effects during radiation. Science Immunology. 6(59). 66 indexed citations
7.
Liu, Longchao, Jiahui Chen, Joonbeom Bae, et al.. (2021). Rejuvenation of tumour-specific T cells through bispecific antibodies targeting PD-L1 on dendritic cells. Nature Biomedical Engineering. 5(11). 1261–1273. 57 indexed citations
8.
Deng, Sisi, Zhichen Sun, Jian Qiao, et al.. (2020). Targeting tumors with IL-21 reshapes the tumor microenvironment by proliferating PD-1intTim-3–CD8+ T cells. JCI Insight. 5(7). 49 indexed citations
9.
10.
Wang, Yang, Juanjuan Zhao, Zhichen Sun, et al.. (2020). Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. UNC Libraries. 1 indexed citations
11.
Peng, Hua, Dan Yang, Lishan Su, et al.. (2020). A mouse model for HBV immunotolerance and immunotherapy. UNC Libraries.
12.
Zhang, Hongyi, Longchao Liu, Jian Zhang, et al.. (2019). Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers. Clinical Cancer Research. 26(6). 1359–1371. 99 indexed citations
13.
Liu, Zhida, Chuanhui Han, Chunbo Dong, et al.. (2019). Hypofractionated EGFR tyrosine kinase inhibitor limits tumor relapse through triggering innate and adaptive immunity. Science Immunology. 4(38). 35 indexed citations
14.
Yang, Kaiting, Yong Liang, Zhichen Sun, et al.. (2018). T cell-derived lymphotoxin limits Th1 response during HSV-1 infection. Scientific Reports. 8(1). 17727–17727. 5 indexed citations
15.
Liu, Xiaojuan, Longchao Liu, Zhenhua Ren, et al.. (2018). Dual Targeting of Innate and Adaptive Checkpoints on Tumor Cells Limits Immune Evasion. Cell Reports. 24(8). 2101–2111. 107 indexed citations
16.
Bian, Yingjie, Zheng Zhang, Zhichen Sun, et al.. (2017). Vaccines targeting preS1 domain overcome immune tolerance in hepatitis B virus carrier mice. Hepatology. 66(4). 1067–1082. 45 indexed citations
17.
Liu, Longchao, Dan Yang, Sherry Fu, et al.. (2016). Clearing Persistent Extracellular Antigen of Hepatitis B Virus: An Immunomodulatory Strategy To Reverse Tolerance for an Effective Therapeutic Vaccination. The Journal of Immunology. 196(7). 3079–3087. 66 indexed citations
18.
Yang, Dan, Longchao Liu, Hua Peng, et al.. (2013). A mouse model for HBV immunotolerance and immunotherapy. Cellular and Molecular Immunology. 11(1). 71–78. 105 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaotao Jiang Breakdown of academic impact, for papers by Nathalie Schmidt Breakdown of academic impact, for papers by Hiroto Matsui Breakdown of academic impact, for papers by Nikola Baschuk Breakdown of academic impact, for papers by Yanan Gao Breakdown of academic impact, for papers by Patrick Roelli Breakdown of academic impact, for papers by Francesca Alfei Breakdown of academic impact, for papers by Giovanni Nitti Breakdown of academic impact, for papers by Jolie G. Cullen
Rankless by CCL
2026